NCT05430373 2026-04-14
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Grit Biotechnology
Phase 1 Recruiting
Grit Biotechnology
HighField Biopharmaceuticals Corporation
Hutchmed
Abbisko Therapeutics Co, Ltd
Jacobio Pharmaceuticals Co., Ltd.
Hutchmed
Shanghai Juncell Therapeutics
Novo Nordisk A/S
Grit Biotechnology
NEC OncoImmunity AS
Shenzhen Celconta Life Science Co., Ltd.
Wuxi People's Hospital
Traws Pharma, Inc.
Shanghai East Hospital
Wuxi People's Hospital